Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice
Mónica Gayoso‐Rey, Olaia Díaz-Trastoy, Elena Yaiza Romero‐Ventosa, Nerea García‐Beloso, Lara González-Freire, Karina Lorenzo‐Lorenzo, Beatriz Mantiñán-Gil, Regina Palmeiro-Carballeira, Marisol Bravo-Amaro, María del Mar López-Gil-Otero, Cristina Martínez‐Reglero, Carlos Crespo-Diz, Pablo Fernández-Catalina, Guadalupe Piñeiro Corrales
Topics & Concepts
MedicineAlirocumabEvolocumabInternal medicineAdverse effectTolerabilityContext (archaeology)Unstable anginaMyocardial infarctionPCSK9Stroke (engine)Retrospective cohort studyGastroenterologyLipoproteinCholesterolMechanical engineeringBiologyEngineeringApolipoprotein A1LDL receptorPaleontologyLipoproteins and Cardiovascular HealthCardiac, Anesthesia and Surgical OutcomesProtease and Inhibitor Mechanisms